Dr. Dana Phillip Woods, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 83 Quarry St, Willimantic, CT 06226 Phone: 860-423-1619 Fax: 860-423-7640 |
Dr. Robert F Dibble, M. D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1120 Main St, Willimantic, CT 06226 Phone: 860-423-2111 Fax: 860-423-7559 |
Dr. Patricia Caton Reardon, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 83 Quarry St, Willimantic, CT 06226 Phone: 860-423-1619 Fax: 860-423-7640 |
News Archive
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care (POC) test for COVID-19.
They reviewed the clinical and laboratory findings as well as the diagnosis and treatment. This study is important since urinary tract infection is one of the most common causes of unexplained fevers in infants with an overall reported prevalence of approximately 10%. infection.
White blood cell (WBC) count may predict cardiovascular events and risk of death in postmenopausal women who are not currently identified by traditional cardiovascular risk factors, according to an article in the March 14 issue of Archives of Internal Medicine.
The George Washington University School of Public Health and Health Services (GW) today released a report representing consensus findings from a cross-section of stakeholders that could help transform the process used to evaluate interventions to treat obesity, a public health crisis that now affects one in three adults. The report, "Obesity Drug Outcome Measures," results from a stakeholder dialogue group convened by GW that, over a period of nine months, explored why development and approval of obesity drugs have proven so difficult.
› Verified 2 days ago